Estrella Immunopharma

ESLANasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$17.621 M

$0.41 -8.66%

Close of 6 Nov 2026

As of 6 Nov 2026, Estrella Immunopharma (ESLA) has a market capitalization of $17.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$13.1M

Loss-making

Shares outstanding

43,497,864

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Estrella Immunopharma lists more than one class of stock. Company figures above cover all classes combined.

ESLAW

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#138BioStem TechnologiesBSEM$19.4M
#139Black Hawk AcquisitionBKHA$18.7M
#140Estrella ImmunopharmaESLA$17.6M
#141PluriPLUR$17.1M
#142Jasper TherapeuticsJSPR$15.6M

What if Estrella Immunopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$649,155.40

Per share 1,602,457× higher

Bitcoin $1.53T

$35,124.67

Per share 86,706× higher

Apple $5.02T

$115,311.01

Per share 284,648× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Estrella Immunopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.